AngioDynamics Inc (ANGO)
6.04
-0.38
(-5.92%)
USD |
NASDAQ |
May 17, 16:00
6.05
+0.01
(+0.17%)
After-Hours: 20:00
AngioDynamics Enterprise Value: 163.48M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 163.48M |
| May 16, 2024 | 178.70M |
| May 15, 2024 | 176.30M |
| May 14, 2024 | 168.69M |
| May 13, 2024 | 166.68M |
| May 10, 2024 | 163.88M |
| May 09, 2024 | 166.68M |
| May 08, 2024 | 157.47M |
| May 07, 2024 | 167.48M |
| May 06, 2024 | 169.89M |
| May 03, 2024 | 172.69M |
| May 02, 2024 | 165.08M |
| May 01, 2024 | 153.46M |
| April 30, 2024 | 153.46M |
| April 29, 2024 | 154.67M |
| April 26, 2024 | 154.27M |
| April 25, 2024 | 153.06M |
| April 24, 2024 | 156.67M |
| April 23, 2024 | 163.08M |
| April 22, 2024 | 172.29M |
| April 19, 2024 | 172.29M |
| April 18, 2024 | 166.68M |
| April 17, 2024 | 175.09M |
| April 16, 2024 | 182.30M |
| April 15, 2024 | 174.29M |
| Date | Value |
|---|---|
| April 12, 2024 | 176.70M |
| April 11, 2024 | 193.92M |
| April 10, 2024 | 195.92M |
| April 09, 2024 | 200.73M |
| April 08, 2024 | 186.31M |
| April 05, 2024 | 205.73M |
| April 04, 2024 | 180.27M |
| April 03, 2024 | 167.33M |
| April 02, 2024 | 171.78M |
| April 01, 2024 | 157.22M |
| March 28, 2024 | 158.84M |
| March 27, 2024 | 151.97M |
| March 26, 2024 | 139.84M |
| March 25, 2024 | 134.59M |
| March 22, 2024 | 138.22M |
| March 21, 2024 | 144.69M |
| March 20, 2024 | 147.52M |
| March 19, 2024 | 145.90M |
| March 18, 2024 | 139.44M |
| March 15, 2024 | 138.63M |
| March 14, 2024 | 140.25M |
| March 13, 2024 | 146.31M |
| March 12, 2024 | 143.48M |
| March 11, 2024 | 142.67M |
| March 08, 2024 | 150.76M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
134.59M
Minimum
Mar 25 2024
1.187B
Maximum
Nov 05 2021
585.73M
Average
539.89M
Median
Oct 25 2022
Enterprise Value Benchmarks
| Becton Dickinson & Co | 83.13B |
| Outset Medical Inc | 156.61M |
| Perspective Therapeutics Inc | 817.27M |
| Xtant Medical Holdings Inc | 116.32M |
| Asensus Surgical Inc | 62.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -187.74M |
| Revenue (Quarterly) | 75.18M |
| Total Expenses (Quarterly) | 86.78M |
| EPS Diluted (Quarterly) | -4.67 |
| Gross Profit Margin (Quarterly) | 47.70% |
| Profit Margin (Quarterly) | -249.7% |
| Earnings Yield | -79.14% |
| Normalized Earnings Yield | -11.31 |